Effect of Endogenous and Exogenous Glucagon on Pentagastrin-stimulated Lower Esophageal Sphincter Pressure in Man
- 1 January 1977
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 12 (1) , 33-36
- https://doi.org/10.1080/00365521.1977.12031107
Abstract
The effect of endogenously released pancreatic glucagon on pentagastrin-stimulated lower esophageal sphincter pressure (LES-P) was studied in 10 healthy subjects. Glucagon was released by continuous i.v. infusion of L-arginine in a dose of 0.6 g/kg-h, which resulted in plasma concentrations of pancreatic glucagon comparable to those seen after a protein meal. Infusion of arginine resulted in a significant inhibition of pentagastrin (0.5 .mu.g/kg-h) stimulated LES-P. Five of the subjects had a study of the effect of exogenous glucagon in a dose of 1.6 .mu.g/kg-h on pentagastrin-stimulated LES-P. This dose of glucagon also reduced LES-P, but despite higher plasma glucagon concentrations, to a lesser degree than arginine.This publication has 7 references indexed in Scilit:
- Inhibition of Gastric Acid Secretion in Man by Exogenous and Endogenous Pancreatic GlucagonGastroenterology, 1976
- PRODUCTION AND EVALUATION OF GLUCAGON ANTIBODIES FOR RADIOIMMUNOASSAYActa Endocrinologica, 1974
- The Effect of Glucagon and the Combined Effect of Glucagon and Secretin on Lower Esophageal Sphincter Pressure in ManScandinavian Journal of Gastroenterology, 1974
- Nature and Kinetics of Inhibition of Lower Esophageal Sphincter Pressure by GlucagonGastroenterology, 1974
- The interaction of glucagon and pentagastrin on the lower oesophageal sphincter in man and dogGut, 1973
- Radioimmunological determination of pancreatic and gut glucagon in plasmaDiabetologia, 1971
- Studies of pancreatic alpha cell function in normal and diabetic subjectsJournal of Clinical Investigation, 1970